Diagnosis

Called ORAiCLE, it can assess the cardiovascular risk of an individual through a retinal scan, more accurately than the current gold standard.

With an initial seed investment of $12 million, Optain becomes the first company announced in Ascertain's growing portfolio of AI companies.

Utah-based Canary Speech partners with major health system to test whether speech patterns can identify MS before traditional methods

New portfolio features AI-powered automation and enhanced liver assessment tools to speed diagnosis and improve clinical workflows

MANAS-1 analyzes 60,000 hours of EEG data to detect epilepsy and mental health conditions with 95% accuracy

Swiss pharmaceutical giant deploys what it calls the largest GPU infrastructure available to any pharma company

Munich startup builds causal AI platform to help healthcare payers identify at-risk patients earlier and cut costs